Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.64% | -10.63% | 10.07% | -52.88% | -68.39% |
| Total Depreciation and Amortization | -6.96% | -9.89% | -9.76% | -12.93% | -8.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.09% | -61.68% | -20.71% | 88.36% | 166.62% |
| Change in Net Operating Assets | -36.47% | 139.41% | -265.95% | 24.47% | -3.29% |
| Cash from Operations | -46.08% | -7.94% | -61.36% | -44.49% | -52.56% |
| Capital Expenditure | 12.62% | 26.67% | -98.11% | -63.16% | -255.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 26.83% | 26.67% | -98.11% | -63.16% | -324.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -84.68% | -99.21% | -96.82% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -85.06% | -99.21% | -96.82% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 357.55% | -1,100.48% | -137.12% | -121.07% | -48.81% |